Man, what is wrong with this company????? It friggin cleared the hurdle of refinancing, so why is it so faaarrrrkkkken volatile and unable to hold on to the misely $11.00 plus mark?????
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market